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DARS-associated leukoencephalopathy
can mimic a steroid-responsive
neuroinflammatory disorder
ABSTRACT
Objective: To describe the expanding clinical spectrum of a recently described hereditary leuko-
encephalopathy, hypomyelination with brainstem and spinal cord involvement and leg spasticity,
which is caused by mutations in the aspartyl tRNA-synthetase encoding gene DARS, including
patients with an adolescent onset.
Methods: Three patients with mutations in DARS were identified by combining MRI pattern rec-
ognition and genetic analysis.
Results: One patient had the typical infantile presentation, but 2 patients with onset in late adoles-
cence had a disease mimicking an acquired inflammatory CNS disorder. Adolescent-onset patients
presented with subacute spastic paraplegia and had positive response to steroids. They had
only minor focal supratentorial white matter abnormalities, but identical spinal cord changes involv-
ing dorsal columns and corticospinal tracts. Clinical presentation included subacute spastic paraple-
gia with partial improvement on steroids.
Conclusions: Focal T2 hyperintense white matter changes on brain MRI in combination with spinal
cord signal abnormalities usually suggest acquired inflammatory conditions such as multiple scle-
rosis, especially in the context of relapsing course and a positive response to steroid treatment.
Adolescents with mutations in DARS can present with a comparable clinical picture, broadening
the clinical spectrum of hypomyelination with brainstem and spinal cord involvement and leg
spasticity. Neurology® 2015;84:226–230
GLOSSARY
AspRS 5 aspartyl tRNA synthetase; HBSL 5 hypomyelination with brainstem and spinal cord abnormalities and leg spas-
ticity; LBSL 5 leukoencephalopathy with brainstem and spinal cord involvement and elevated lactate; MS 5 multiple scle-
rosis; WES 5 whole-exome sequencing.
Hypomyelination with brainstem and spinal cord abnormalities and leg spasticity (HBSL,
OMIM 615281) is an inherited white matter disorder caused by autosomal recessive muta-
tions in DARS, encoding the cytosolic aspartyl tRNA synthetase (AspRS).1 HBSL was first
described in 10 patients, all of whom had a severe presentation with infantile onset and
extensive MRI signal abnormalities of the supratentorial white matter suggesting hypomy-
elination, as well as signal changes in the spinal cord. HBSL affects the same tracts as
leukoencephalopathy with brainstem and spinal cord involvement and elevated lactate
(LBSL),1 a disease caused by mutations in DARS2, encoding the mitochondrial counterpart
of AspRS.2,3
Since the original publication, we identified 3 more patients, one with typical infantile onset
and 2 young adults with disease onset in late adolescence, both with focal cerebral white matter
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abnormalities, spinal cord signal abnormali-
ties, subacute disease onset, and partial steroid
responsiveness, mimicking a neuroinflamma-
tory disease.
METHODS Patients were identified from the databases of the
Center for Children withWhite Matter Disorders, VUUniversity
Medical Center, Amsterdam, the Netherlands; The Undiagnosed
Diseases Program at the NIH, Bethesda, Maryland; and the
Department of Neurology, Children’s National Medical Center,
Washington, DC. Brain and spinal cord MRIs were analyzed
using MRI pattern recognition.4,5 DARS sequencing was per-
formed as described previously.1
Standard protocol approvals, registrations, and patient
consents. The institutional review boards of these institutions
approved this study, and appropriate informed consent was obtained.
RESULTS Clinical presentation. Patient 1 developed
normally until the age of 14 months, when, after a
brief viral illness, she became irritable and lost several
words and the ability to sit without support. She sub-
sequently developed nystagmus and leg spasticity. She
showed striking improvement in axial muscle tone
and strength after oral ibuprofen treatment initiated
for discomfort at teething. Steroids were without
additional beneficial effect. She continued to make
slow progress and learned to walk with support.
Her cognitive abilities were above average.
Patient 2 is a 22-year-old man who was involved
in a traffic accident at age 18, resulting in brief loss
of consciousness and a small subdural bleed. He
recovered completely within 2 days. One month later,
he presented with progressive weakness of his legs
more than his arms. He experienced rapid deteriora-
tion and lost the ability to walk without support in
the course of 3 months. Neurologic examination re-
vealed ataxia, leg spasticity, diffuse hyperreflexia with
bilateral extensor plantar responses, and distal
decrease in position and vibration sense of both legs.
There were no oligoclonal bands present in CSF. He
received one course of IV steroids (1,000 mg methyl-
prednisolone per day for 5 days) and thereafter grad-
ually regained the ability to ambulate within 1 year.
Two years later, he had mild residual leg spasticity.
Patient 3 is a 20-year-old woman who developed
progressive leg spasticity and urinary urgency and
frequency from the age of 16 years. There were no
oligoclonal bands present in CSF. Initially, a neuro-
inflammatory condition such as multiple sclerosis
(MS) was suspected and she received steroid pulse
treatments every 3 to 6 months (1,000 mg methyl-
prednisolone per day for 3 days). Her symptoms
would improve within days, but then slowly re-
emerge over months until the next treatment was
administered. The possibility of hereditary spastic
paraplegia was considered in view of signal changes
in the long tracts over the entire length of the spinal
cord. Whole-exome sequencing (WES) was per-
formed to ascertain the molecular basis of her
disease.
DARS mutations. In patients 1 and 2, the original sus-
picion was LBSL, but we detected no pathogenic
DARS2mutations. Mutations inDARS were detected
subsequently by Sanger sequencing. The DARS
mutation in patient 3 was identified by WES.
Patient 1 was compound heterozygous for
c.599C.G; p.Ser200Cys and c.830C.T; p.Ser277Phe.
Patient 2 was homozygous for c.1277T.C; p.Leu426-
Ser, and patient 3 compound heterozygous for
c.839A.T; p.His280Leu and c.1099G.C; p.As-
p367His (figure 1).
MRI abnormalities. Brain MRI of the patient with
infantile onset showed homogeneous T2 hyperinten-
sity of the supratentorial white matter with sparing of
the U-fibers. This T2 hyperintensity was more pro-
nounced than usually seen in other children with
HSBL. In contrast, in the 2 patients with adolescent
onset, brain MRI showed only limited, focal areas of
Figure 1 Positioning of DARS mutations in individuals with hypomyelination
with brainstem and spinal cord abnormalities and leg spasticity
The images show the crystal structure of human aspartyl tRNA synthetase (AspRS) pro-
tein (PDB:4J15) including the catalytic domain (olive), and the hinge and the anticoding
binding domains (gray). All hypomyelination with brainstem and spinal cord abnormalities
and leg spasticity–associated variants (spheres) identified to date are located within the
catalytic domain: p.Ser200 (red), p.Leu426 (brown), and p.Asp367 (green) (this publica-
tion); p.Met256 (red), p.Arg460 (blue), p.Pro464 (cyan), p.Arg487 (orange), and p.Arg494
(magenta).1 The residues p.Ala274, p.Ser277, and p.His280 are not shown as they reside
in a 9-residue loop that is disordered and therefore missing from this structure. The loop is
known to be dynamic until docked with its cognate tRNA.9
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T2 hyperintensity in the periventricular region. Mye-
lination was normal (figure 2). There was no contrast
enhancement.
Spinal cord imaging in all patients showed abnor-
mal T2 hyperintense signal of the dorsal columns
(nonhomogeneously in patient 3) and the lateral
Figure 2 Brain MRI
Brain MRI in patients with infantile and adult onset. (First row) Patient 1, age 2 years. Hyperintense T2 signal of the infe-
rior cerebellar peduncles (A; arrow) and the supratentorial white matter sparing the U fibers (B, C). Corresponding hypo-
intense T1 signal of the centrum semiovale, again with sparing of the U fibers (D). (Second row) MRI of patient 2, age 19
years. (E) Hyperintense T2 signal of the pyramids in the medulla oblongata (white arrow). (F-H) Focal periventricular signal
changes with hyperintense T2 signal; myelination is normal. (Third row) Patient 3, age 18 years, without changes in brain-
stem or cerebellar white matter (I, J). The patient has focal periventricular hyperintense T2 signal changes (K, L). (Fourth
row) For comparison, a patient aged 9 years with classic hypomyelination with brainstem and spinal cord abnormalities
and leg spasticity and characteristic MRI abnormalities (patient 4 from Taft et al.,1 2013) shows signal abnormalities of
the brainstem, including corticospinal tracts, medial lemniscus, and inferior (arrow) and superior cerebellar peduncles (M,
N) and diffuse hyperintense T2 signal of the entire supratentorial white matter typical of hypomyelination (O, P) also
involving the U fibers.
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corticospinal tracts. Patient 2 additionally showed
prominent involvement of the anterior corticospinal
tracts (figure 3).
DISCUSSION HBSL was initially described as an
infantile onset disease.1 Identification of adult
patients with presentation in late adolescence and
only focal white matter changes on brain MRI
extends the disease spectrum beyond the infantile
phenotype. All patients identified so far carried mis-
sense mutations leading to amino acid changes in the
catalytic domain of AspRS.
Several patients with the classical form of HBSL
—patient 1 in this study, and 2 out of 10 patients in
the original series1—showed regression after mild
viral illness or vaccination. The 2 patients with ado-
lescent onset showed subacute deterioration. In 4
patients (patients 2 and 3 in this study and 2 patients
from the original description), administration of ste-
roids was followed by clinical improvement and was
assumed to be responsible for the partial recovery
these patients experienced. The relapsing-remitting
clinical course, response to steroids, and combina-
tion of focal white matter and spinal cord signal
changes would usually suggest an inflammatory
demyelinating disorder such as MS or neuromyelitis
optica. Thus, HBSL should be included in the dif-
ferential diagnosis of CNS inflammatory disorders.
A clue to HBSL is the selective involvement of spe-
cific spinal tracts over the entire length of the spinal
cord, which argues against a primary inflammatory
CNS disease.
Notably, 2 children from the original study had an
additional spinal cord abnormality, namely tether-
ing.1 The current number of patients is too small to
determine if this is a chance association, but a teth-
ered cord might be another feature of DARS muta-
tions. Patients with HBSL should be investigated
with spinal imaging to detect this complication.
LBSL and HBSL show some striking similarities,1
but also differences. The typical clinical course in
LBSL is slowly progressive, although 2 patients with
sudden deterioration after a mild head trauma fol-
lowed by fever have been reported.6 Infantile onset
with severe disease course is rare in LBSL. MRI in
these cases shows diffuse supratentorial white matter
abnormalities, reminiscent of those seen in HBSL,7,8
whereas in most LBSL cases, supratentorial signal
changes are focal.2,8 The intraparenchymal trajectories
of the trigeminal nerves and mesencephalic trigeminal
tracts are typically affected in LBSL,2 but normal in
HBSL.1 Still, the finding of a mild adult phenotype of
HBSL with only focal brain white matter abnormal-
ities and spinal cord changes similar to those seen in
LBSL reinforces the possibility that there may be a
common pathogenic mechanism. Intriguingly, recent
Figure 3 Spinal cord MRI
Findings on spinal cord MRI. (A–C) Patient 1, abnormal signal of dorsal columns and lateral corticospinal tracts. (D, E) Patient
2, abnormal signal of dorsal columns and anterior and lateral corticospinal tracts. (F, G) Patient 3, signal changes in dorsal
columns and lateral corticospinal tracts. For comparison, 2 previously described patients1 are shown with the typical signal
changes, as well as tethering (H, I) and syringomyelia (I).
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structural data have demonstrated a similar 3D struc-
ture of both cytosolic and mitochondrial AspRS
despite poor sequence homology of their respective
genes, raising the possibility of functional overlap in
situ, which might provide clues to the striking paral-
lels between LBSL and HBSL.9
Cytosolic AspRS is part of the multisynthetase
complex,10 which appears to play an important role
not only in tRNA synthesis, but also in multiple cel-
lular processes, including cytokine and immune re-
sponses.11 The apparent positive response of several
patients with HBSL to anti-inflammatory treatment
might be related to these alternative functions. There-
fore, treatment with steroid pulse therapy might be
considered in HBSL, especially in the case of (sub)
acute deterioration. Careful determination of clinical
outcome goals and treatment duration needs to be
individualized for each patient.
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